CD274 and cancer: Increasing evidence suggests that PD‐1 (programmed cell death‐1), as an important immune checkpoint molecule, is mainly expressed on immune cells and negatively regulates antigen‐specific T‐cell immunity by binding to its receptor PD‐L1 (programmed cell death‐1), acting as immunosuppressive and contributing to cancer evasion.5